Top surgery breakthrough: common drug may cut complications
NCT ID NCT05794321
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 26 times
Summary
This study tests whether giving a drug called tranexamic acid (TXA) through an IV during gender affirming mastectomy (top surgery) can lower the risk of hematomas (blood collections) and seromas (fluid collections). About 150 adults having top surgery at UCSF will be randomly assigned to receive TXA or not. The goal is to see if TXA reduces bleeding, drain use, and recovery time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE HEMATOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCSF Department of Plastic & Reconstructive Surgery
RECRUITINGSan Francisco, California, 94131, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.